Harnessing host innate immunity may combat acquired resistance to BRAFi

Por Tan, Thomas, Pangigadde, Pradeepa, Sabbatino, Francesco, Favoino, Elvira, Orgiano, Laura, Ferrone, Soldano, Carbone, Ennio, Colucci, Francesco
Publicado em 2014

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

Por Spagnolo, Francesco, Ghiorzo, Paola, Orgiano, Laura, Pastorino, Lorenza, Picasso, Virginia, Tornari, Elena, Ottaviano, Vincenzo, Queirolo, Paola
Publicado no Onco Targets Ther (2015)

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

Por Sottile, Rosa, Pangigadde, Pradeepa N., Tan, Thomas, Anichini, Andrea, Sabbatino, Francesco, Trecroci, Francesca, Favoino, Elvira, Orgiano, Laura, Roberts, James, Ferrone, Soldano, Kärre, Klas, Colucci, Francesco, Carbone, Ennio
Publicado no Eur J Immunol (2015)